Insiders buying IONS and BDN stock, believing in good performance

From Nasdaq: 2025-05-05 13:47:00

Bargain hunters should take note of recent insider buying activity, as insiders typically invest because they believe the stock will perform well. Ionis Pharmaceuticals’ Director, Michael R. Hayden, purchased $477,900 worth of IONS stock, currently up 6.7%. CEO Gerard H. Sweeney also bought $250,614 of Brandywine Realty Trust shares. Ionis Pharmaceuticals is trading up 2.8% Monday, while Brandywine Realty Trust is up 0.5%. Hayden previously bought $181,079 worth of shares. Insider buying can be a positive sign for investors looking for potential opportunities in the market.



Read more at Nasdaq: Monday 5/5 Insider Buying Report: IONS, BDN